Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 114 is a human pseudogene located on chromosome 9. It is related by sequence to the functionally characterized 7SK small nuclear RNA (RN7SK), but as a pseudogene, RN7SKP114 does not encode a functional transcript or protein[2][3]. The functional RN7SK RNA participates in regulation of transcription elongation by modulating the positive transcription elongation factor P-TEFb in cells[1]. Pseudogenes such as RN7SKP114 typically arise through duplication or retrotransposition events and are generally non-functional remnants in the genome, with no known roles in normal physiology or disease[2][3]. No evidence supports the therapeutic targeting of RN7SKP114, and it is not considered a drug target.\n\nIf detailed functional or clinical data are required, information should be sought for the functional gene "RN7SK" (not RN7SKP114), which plays a regulatory role in transcription[1][5]. RN7SKP114 itself is not a therapeutic target and does not encode any receptor, enzyme, transporter, or similar druggable entity[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 114 (RN7SKP114).